nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Dactinomycin—ocular cancer	0.712	0.806	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—ocular cancer	0.172	0.194	CbGbCtD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.000894	0.00767	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—HDAC1—ocular cancer	0.000872	0.00748	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—RB1—ocular cancer	0.000847	0.00727	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.000843	0.00723	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.000713	0.00612	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—ocular cancer	0.000706	0.00606	CbGpPWpGaD
Mifepristone—AR—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.000695	0.00597	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—E2F5—ocular cancer	0.000686	0.00589	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—E2F4—ocular cancer	0.000672	0.00577	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.000667	0.00573	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000666	0.00572	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—CDKN1B—ocular cancer	0.00066	0.00566	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—RBL1—ocular cancer	0.000659	0.00566	CbGpPWpGaD
Mifepristone—AR—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.000656	0.00563	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.000645	0.00554	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.000639	0.00549	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.000631	0.00541	CbGpPWpGaD
Mifepristone—AR—FOXA1 transcription factor network—EP300—ocular cancer	0.000611	0.00524	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.000594	0.0051	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—EP300—ocular cancer	0.000579	0.00497	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.000571	0.0049	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—SF3B1—ocular cancer	0.000563	0.00483	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.000556	0.00478	CbGpPWpGaD
Mifepristone—AR—Nongenotropic Androgen signaling—HRAS—ocular cancer	0.000553	0.00475	CbGpPWpGaD
Mifepristone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—ocular cancer	0.000532	0.00457	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—TFDP1—ocular cancer	0.000531	0.00456	CbGpPWpGaD
Mifepristone—AR—Regulation of Androgen receptor activity—EP300—ocular cancer	0.000526	0.00452	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—E2F5—ocular cancer	0.000523	0.00449	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.000518	0.00444	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—E2F4—ocular cancer	0.000512	0.00439	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CCND1—ocular cancer	0.000511	0.00438	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—RB1—ocular cancer	0.000508	0.00436	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.000506	0.00434	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—RBL1—ocular cancer	0.000502	0.00431	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.000498	0.00427	CbGpPWpGaD
Mifepristone—AR—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.000488	0.00419	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.000478	0.00411	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00047	0.00403	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—MDM2—ocular cancer	0.000434	0.00372	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SF3B1—ocular cancer	0.000429	0.00368	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000424	0.00364	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.000422	0.00362	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MAML2—ocular cancer	0.000422	0.00362	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00042	0.00361	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000412	0.00354	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.000411	0.00353	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.000405	0.00348	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—TFDP1—ocular cancer	0.000405	0.00347	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—E2F1—ocular cancer	0.000402	0.00345	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—EP300—ocular cancer	0.000399	0.00343	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—EIF1AX—ocular cancer	0.000397	0.00341	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—E2F5—ocular cancer	0.000397	0.0034	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.000394	0.00338	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000389	0.00334	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—E2F4—ocular cancer	0.000388	0.00333	CbGpPWpGaD
Mifepristone—NR3C1—Circadian Clock—EP300—ocular cancer	0.000388	0.00333	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.000383	0.00329	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—RBL1—ocular cancer	0.000381	0.00327	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.000379	0.00325	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CCND1—ocular cancer	0.000378	0.00324	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.000375	0.00322	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—MDM2—ocular cancer	0.000371	0.00318	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.000365	0.00313	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.000364	0.00312	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.000351	0.00301	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EP300—ocular cancer	0.000348	0.00298	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCND1—ocular cancer	0.000347	0.00298	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1B—ocular cancer	0.000339	0.00291	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000336	0.00288	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.000333	0.00286	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—E2F5—ocular cancer	0.00033	0.00283	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00033	0.00283	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.000327	0.0028	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SF3B1—ocular cancer	0.000326	0.00279	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—E2F4—ocular cancer	0.000324	0.00278	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MAML2—ocular cancer	0.000322	0.00276	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—EP300—ocular cancer	0.00032	0.00274	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000317	0.00272	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RPL39—ocular cancer	0.000317	0.00272	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RBL1—ocular cancer	0.000317	0.00272	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1A—ocular cancer	0.000312	0.00268	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—HDAC1—ocular cancer	0.000309	0.00265	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—TFDP1—ocular cancer	0.000307	0.00264	CbGpPWpGaD
Mifepristone—AR—Gene Expression—EIF1AX—ocular cancer	0.000302	0.0026	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.000299	0.00256	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.000296	0.00254	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PSPH—ocular cancer	0.000286	0.00245	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—RB1—ocular cancer	0.000285	0.00244	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.000284	0.00244	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—TGFB1—ocular cancer	0.000284	0.00244	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—AKT1—ocular cancer	0.000284	0.00244	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000284	0.00244	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.000282	0.00242	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00028	0.0024	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MYC—ocular cancer	0.000278	0.00239	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TGFB1—ocular cancer	0.000278	0.00238	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.000277	0.00237	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—RBBP4—ocular cancer	0.000275	0.00236	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00026	0.00223	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—TFDP1—ocular cancer	0.000256	0.00219	CbGpPWpGaD
Mifepristone—AR—Gene Expression—E2F5—ocular cancer	0.000252	0.00216	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PSPH—ocular cancer	0.000249	0.00214	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.000248	0.00213	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000247	0.00212	CbGpPWpGaD
Mifepristone—AR—Gene Expression—E2F4—ocular cancer	0.000247	0.00212	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MAML2—ocular cancer	0.000244	0.00209	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SAG—ocular cancer	0.000243	0.00208	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RPL39—ocular cancer	0.000242	0.00207	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RBL1—ocular cancer	0.000242	0.00207	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000235	0.00202	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—HDAC1—ocular cancer	0.000235	0.00202	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—EIF1AX—ocular cancer	0.000229	0.00197	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—ocular cancer	0.000229	0.00196	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000228	0.00195	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000226	0.00194	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SAG—ocular cancer	0.000226	0.00194	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000222	0.0019	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000215	0.00184	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—E2F5—ocular cancer	0.000215	0.00184	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.000211	0.00181	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—E2F4—ocular cancer	0.00021	0.00181	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.00021	0.0018	CbGpPWpGaD
Mifepristone—AR—Gene Expression—RBBP4—ocular cancer	0.00021	0.0018	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RBL1—ocular cancer	0.000206	0.00177	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000205	0.00176	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CDKN1A—ocular cancer	0.000205	0.00176	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—ocular cancer	0.000203	0.00175	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAML2—ocular cancer	0.000203	0.00174	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.000201	0.00173	CbGpPWpGaD
Mifepristone—ABCC1—Disease—E2F5—ocular cancer	0.0002	0.00172	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000199	0.00171	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000198	0.0017	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000198	0.0017	CbGpPWpGaD
Mifepristone—ABCC1—Disease—E2F4—ocular cancer	0.000196	0.00168	CbGpPWpGaD
Mifepristone—AR—Gene Expression—TFDP1—ocular cancer	0.000195	0.00167	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RPL39—ocular cancer	0.000192	0.00165	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RBL1—ocular cancer	0.000192	0.00165	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—E2F5—ocular cancer	0.000191	0.00164	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000189	0.00162	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—E2F4—ocular cancer	0.000187	0.00161	CbGpPWpGaD
Mifepristone—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000185	0.00158	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RPL39—ocular cancer	0.000183	0.00157	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RBL1—ocular cancer	0.000183	0.00157	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PSPH—ocular cancer	0.00018	0.00155	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00018	0.00154	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—AKT1—ocular cancer	0.00018	0.00154	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—E2F3—ocular cancer	0.000179	0.00154	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—HDAC1—ocular cancer	0.000178	0.00153	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000173	0.00148	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.000172	0.00147	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.00017	0.00146	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TGFB1—ocular cancer	0.000169	0.00145	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000168	0.00144	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TFDP1—ocular cancer	0.000166	0.00143	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000164	0.00141	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000164	0.00141	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000163	0.0014	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00016	0.00137	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—RBBP4—ocular cancer	0.000159	0.00136	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000159	0.00136	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TFDP1—ocular cancer	0.000155	0.00133	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAML2—ocular cancer	0.000155	0.00133	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HDAC1—ocular cancer	0.000149	0.00127	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—TFDP1—ocular cancer	0.000148	0.00127	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000138	0.00118	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000137	0.00117	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSPH—ocular cancer	0.000136	0.00117	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000135	0.00116	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000135	0.00116	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CDKN2B—ocular cancer	0.000133	0.00114	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAML2—ocular cancer	0.000132	0.00113	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000129	0.00111	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSPH—ocular cancer	0.000128	0.0011	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAML2—ocular cancer	0.000123	0.00106	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAML2—ocular cancer	0.000117	0.00101	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GNA11—ocular cancer	0.000115	0.000989	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000114	0.000979	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HDAC1—ocular cancer	0.000113	0.000971	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000109	0.000933	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—ocular cancer	0.000107	0.00092	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GNAQ—ocular cancer	0.000107	0.00092	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CDKN2B—ocular cancer	0.000101	0.000871	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HDAC1—ocular cancer	9.66e-05	0.000829	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.59e-05	0.000823	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HDAC1—ocular cancer	9e-05	0.000773	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GNA11—ocular cancer	9e-05	0.000772	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	8.76e-05	0.000752	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN2B—ocular cancer	8.66e-05	0.000743	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HDAC1—ocular cancer	8.59e-05	0.000737	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSPH—ocular cancer	8.38e-05	0.000719	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GNAQ—ocular cancer	8.37e-05	0.000718	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	8.35e-05	0.000717	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—ocular cancer	8.17e-05	0.000701	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	8.08e-05	0.000694	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN2B—ocular cancer	8.07e-05	0.000693	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—E2F1—ocular cancer	7.95e-05	0.000682	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GNA11—ocular cancer	7.85e-05	0.000673	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CDKN2B—ocular cancer	7.7e-05	0.000661	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.69e-05	0.00066	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GNAQ—ocular cancer	7.3e-05	0.000626	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.75e-05	0.000579	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.7e-05	0.000575	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.69e-05	0.000574	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—ocular cancer	6.2e-05	0.000532	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GNA11—ocular cancer	5.67e-05	0.000487	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.5e-05	0.000472	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GNAQ—ocular cancer	5.27e-05	0.000453	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—ocular cancer	5.16e-05	0.000443	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MDM2—ocular cancer	4.8e-05	0.000412	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.65e-05	0.000399	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MDM2—ocular cancer	4.48e-05	0.000384	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—ocular cancer	4.39e-05	0.000376	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNA11—ocular cancer	4.28e-05	0.000367	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—ocular cancer	4.18e-05	0.000359	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—ocular cancer	4.09e-05	0.000351	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—ocular cancer	4.05e-05	0.000347	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNA11—ocular cancer	4.03e-05	0.000346	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNAQ—ocular cancer	3.98e-05	0.000342	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—ocular cancer	3.93e-05	0.000337	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—ocular cancer	3.85e-05	0.00033	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—ocular cancer	3.77e-05	0.000324	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNAQ—ocular cancer	3.75e-05	0.000322	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—ocular cancer	3.59e-05	0.000308	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—ocular cancer	3.58e-05	0.000307	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—ocular cancer	3.36e-05	0.000288	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—ocular cancer	3.35e-05	0.000287	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—ocular cancer	3.13e-05	0.000268	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—ocular cancer	3.12e-05	0.000268	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—ocular cancer	3.01e-05	0.000258	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—ocular cancer	2.98e-05	0.000256	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—ocular cancer	2.76e-05	0.000237	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—ocular cancer	2.73e-05	0.000234	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNA11—ocular cancer	2.64e-05	0.000226	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—ocular cancer	2.64e-05	0.000226	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—ocular cancer	2.62e-05	0.000225	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—ocular cancer	2.46e-05	0.000211	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNAQ—ocular cancer	2.45e-05	0.00021	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—ocular cancer	2.33e-05	0.0002	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—ocular cancer	2.17e-05	0.000186	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—ocular cancer	2.07e-05	0.000178	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—ocular cancer	1.9e-05	0.000163	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—ocular cancer	1.82e-05	0.000156	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—ocular cancer	1.58e-05	0.000136	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—ocular cancer	1.43e-05	0.000123	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—ocular cancer	1.35e-05	0.000116	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—ocular cancer	1.15e-05	9.83e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—ocular cancer	8.81e-06	7.56e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—ocular cancer	8.64e-06	7.42e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—ocular cancer	8.14e-06	6.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—ocular cancer	5.32e-06	4.57e-05	CbGpPWpGaD
